CeCors IncOTC Pink - Current Information:CEOS
- LAST PRICE0.0190
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0180 / 0.0190
- Day Range
- 52 Week Range
- Volume546,939
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CEOS |
|---|---|---|
| 09:32 ET | 55280 | 0.018 |
| 09:36 ET | 94050 | 0.01795 |
| 09:56 ET | 50000 | 0.0179 |
| 10:48 ET | 5000 | 0.01795 |
| 10:55 ET | 20609 | 0.01795 |
| 10:57 ET | 220000 | 0.018 |
| 11:04 ET | 50000 | 0.018 |
| 11:06 ET | 40000 | 0.01856 |
| 02:06 ET | 1000 | 0.01895 |
| 02:11 ET | 1000 | 0.019 |
| 03:43 ET | 10000 | 0.01897 |
Apr 9, 2024
VETCOMM Opens New Headquarters: Poised for Enhanced Operations and Team Collaboration, from 9:31AM ET on Tuesday Apr 09, 2024 by Dow Jones
9:31AM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 1, 2024
VETCOMM's Subscription Sales Surge Past $786,000 in 2023; CEOS Prepares for a Record First Quarter in 2024, from 11:18AM ET on Monday Apr 01, 2024 by Dow Jones
11:18AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 21, 2024
Award-Winning Journalist Rafer Weigel Appointed Chief Content Officer at VETCOMM, Elevating CeCors' Strategic Content Vision, from 9:33AM ET on Thursday Mar 21, 2024 by Dow Jones
9:33AM ET on Thursday Mar 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CeCors Inc | 6.0M | 0.0x | --- |
Protagenic Therapeutics Inc | 6.0M | -1.2x | --- |
Avenue Therapeutics Inc | 6.0M | -0.1x | --- |
HST Global Inc | 5.9M | -40.2x | --- |
PaxMedica Inc | 5.9M | 0.0x | --- |
Actavia Life Sciences Inc | 6.0M | -1.0x | --- |
Company Information
CeCors, Inc. is engaged in the acquisition and development of Emerging Technologies, as well as healthcare and data-related companies. The Company is focused on the health and technology sector, as well as other emerging technologies, primarily on the mental health market through its investment and development of its TeleMed (Telemedicine) Network connecting patients with medical professionals. The Company uses the same network through its CannMedLive, which assists medical cannabis candidates by connecting them with physicians that diagnose and suggest appropriate treatment.
Contact Information
- Headquarters
- 854 Upper Canada DriveSARNIA, ON, Canada N7W 1A4
- Phone
- 480-659-8036
- Fax
- 714-768-8737
Executives
- President, Director
- Bob Gardiner
- Chief Executive Officer
- Kate Monroe
- Vice President, Director
- Allen Greenspoon
- Treasurer, Secretary, Director
- Jasbir Kang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.0M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 332.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.36 |
EPS | --- |
Book Value | $0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
